metformin and semaglutide vs Efficacy safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial niceguidelines #metformin #semaglutide #tirzepatide |

Verma A, Pathak P, Rimac H, Khalilullah H, Kumar V, Grishina M, Potemkin V, Ahmed B

Plaintiffs pursuing such claims now face two choices: they can either file a new MDL focusing solely on blood clot injuries or litigate the cases separately in state or federal courts nationwide

Here is a rough timeline based on the clinical data: Days 1 to 7: Appetite suppression begins, food intake drops Weeks 2 to 4: First noticeable weight loss, typically 1 to 3 kg depending on starting weight and dose Weeks 4 to 12: Consistent weekly weight loss, metabolic markers like fasting glucose and triglycerides start improving Weeks 12 to 24: Significant body composition changes, energy levels often stabilize, some people report improved sleep Weeks 24 to 48: Weight loss continues but slows as the body approaches a new set point, full metabolic remodeling occurs The full effects of retatrutide are not just about weight

As use expands, so does a common concern: can GLP-1 medications cause low blood sugar in people who dont have diabetes

Rather than focusing only on the number on the scale during your first week, look for other positive changeslike increased energy, better sleep, or improved moodthat show your body is responding to your personalized plan

Tirzepatide launched at a higher price than semaglutide